Bruker Daltonics (Nasdaq: BRKR) announced collaborations in the United States for the clinical validation of its MALDI Biotyper workflow for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE